Cargando…

332. Exploring the Prevalence and Characteristics of Weight Gain and other Metabolic Changes in Patients with HIV Infection Switching to Integrase Inhibitor Containing ART

BACKGROUND: Excessive weight gain in patients living with HIV (PLWH) can have considerable health-related consequences. Recent observational studies suggest that patients initiating or switching to integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) may experience weight g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmerman, Matty, DeSimone, Joseph, Schafer, Jason J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810494/ http://dx.doi.org/10.1093/ofid/ofz360.405

Ejemplares similares

Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens
por: Norwood, Jamison, et al.
Publicado: (2017)

979. BMI and ASCVD Risk Score Changes in Virologically Suppressed Patients with HIV Switching from TDF to TAF Containing ART
por: Schafer, Jason J, et al.
Publicado: (2019)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021)

1566. Determinants associated with weight gain among persons with HIV who switch to integrase strand transfer inhibitors (INSTI)
por: Cutshaw, Melissa Klein, et al.
Publicado: (2023)

828. Short- and Long-Term Metabolic Changes in Virologically Suppressed Patients Switching from TDF to TAF Containing Antiretroviral Therapy
por: Schafer, Jason J, et al.
Publicado: (2021)

1049. Weight Gain in Persons Living with HIV (PLWH) Treated with Bictegravir Compared to Other Integrase Strand Transfer Inhibitors
por: Fang, Michelle, et al.
Publicado: (2020)

Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors
por: Donga, Prina, et al.
Publicado: (2022)

946. Risk factors and Metabolic Implications of Integrase Inhibitor Associated Weight Gain
por: Asundi, Archana, et al.
Publicado: (2020)

Case Report: Reversal of Integrase Inhibitor– and Tenofovir Alafenamide–Related Weight Gain After Switching Back to Efavirenz/Emtricitabine/Tenofovir DF
por: Pohlman, F Will, et al.
Publicado: (2021)

Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGE(h)IV cohort participants
por: Verboeket, Sebastiaan O., et al.
Publicado: (2021)

Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?
por: Wood, Brian R, et al.
Publicado: (2021)

One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor
por: Verburgh, Myrthe L, et al.
Publicado: (2022)

1985. A Prospective, Randomized Trial to Assess a Protease Inhibitor–based Regimen Switch Strategy to Manage Integrase Inhibitor–related Weight Gain
por: Short, William R, et al.
Publicado: (2023)

No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain
por: Verburgh, Myrthe L., et al.
Publicado: (2023)

P332: Abstract withdrawn
Publicado: (2013)

Autoimmunity against laminin 332
por: Patzelt, Sabrina, et al.
Publicado: (2023)

1987. "Association Between Integrase Inhibitor Plasma Concentrations and Body Weight Gain in Women Living with HIV"
por: Lahiri, Cecile D, et al.
Publicado: (2023)

Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort
por: Koay, Wei Li A, et al.
Publicado: (2021)

334. Weight Change Associated with Antiretroviral Therapy Switch to Integrase Strand Transfer Inhibitor-Based Regimens
por: Saber, Saghar, et al.
Publicado: (2019)

107. Impact of Switching to an Antiretroviral Regimen Containing Tenofovir Alafenamide on Weight Gain and Development of Metabolic Side Effects
por: Darnell, Julia, et al.
Publicado: (2020)

Impact of switching to tenofovir alafenamide on weight gain as compared to maintaining a non-tenofovir alafenamide containing regimen
por: Darnell, Julia, et al.
Publicado: (2021)

1043. The impact of integrase strand transfer inhibitors (InSTIs) on weight gain among adults with HIV in clinical care
por: Thatipelli, Sneha, et al.
Publicado: (2020)

Genetic switches designed for eukaryotic cells and controlled by serine integrases
por: Gomide, Mayna S., et al.
Publicado: (2020)

Laminin 332 processing impacts cellular behavior
por: Rousselle, Patricia, et al.
Publicado: (2013)

Keratinocyte footprint assay discriminates antilaminin‐332 pemphigoid from all other forms of pemphigoid diseases
por: Giurdanella, F., et al.
Publicado: (2019)

Reduction in the weight, gained due to dolutegravir, following switch to bictegravir
por: Saple, Dattatray, et al.
Publicado: (2022)

Integrase Strand Transfer Inhibitors Play the Main Role in Greater Weight Gain Among Men With Acute and Early HIV Infection
por: Wu, Kuan-Sheng, et al.
Publicado: (2020)

Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens
por: Kim, Jin, et al.
Publicado: (2022)

Identification of low molecular weight nuclear complexes containing integrase during the early stages of HIV-1 infection
por: Gérard, Annabelle, et al.
Publicado: (2013)

Anti-Laminin 332-Type Mucous Membrane Pemphigoid
por: Shi, Luhuai, et al.
Publicado: (2022)

333. Weight Gain Among HIV-Infected Patients in Southern India on Treatment with Integrase Strand Transfer Inhibitor-based Antiretroviral Therapy
por: Khan, Rifa, et al.
Publicado: (2019)

Effects of Integrase Inhibitor–Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV
por: Toribio, Mabel, et al.
Publicado: (2020)

952. Weight-Gain in Treatment Naive Newly Diagnosed HIV-Infected Persons After Initiation on Integrase Strand Inhibitor Based Treatment Regimens
por: Szep, Zsofia, et al.
Publicado: (2020)

Switching to Integrase Inhibitors Unlinked to Weight Increase in Perinatally HIV-Infected Young Adults and Adolescents: A 10-Year Observational Study
por: Taramasso, Lucia, et al.
Publicado: (2020)

332 Project for Prevention & Control of Asthma and Allergic Diseases in Korea
por: Chung, Eun Hee, et al.
Publicado: (2012)

332 National trends of dermatology procedures during the COVID pandemic
por: Raiker, R., et al.
Publicado: (2021)

Metformin and the risk of dementia based on an analysis of 396,332 participants
por: Ji, Shiliang, et al.
Publicado: (2022)

FRI332 Check Point Inhibitor Induced Hypophysitis/Hypopituitarism
por: Chandpuri, Ranjit Singh
Publicado: (2023)

Sonate A-Dur (nach KV331/332) für Flöte und Gitarre = Sonata A major (after KV331/332) for flute and guitar /
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1978)

538. Integrase Inhibitor-Based HAART Is Associated with Greater BMI Gains in Blacks, Hispanics, and Women
por: Bedimo, Roger, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pnamvttu0m4mc0g4gqnvl4n4lo